1. Shreya Das, Nidhi Shukla, Shashi Shekhar Singh, Sapana Kushwaha, Richa Shrivastava. Mechanism of interaction between autophagy and apoptosis in cancer. Apoptosis.2021. Impact Factor-4.6
2. Abstract: Abhishek Jaiswal, Nidhi Shukla, Shashi Shekhar Singh, Richa Shrivastava, Archismita Santra, Ankita Jaiswal, Harshal Salve, 1537: Fighting against the pandemic or threatening the environment? Unforeseen challenges during COVID-19 pandemic, International Journal of Epidemiology.2021 (50):1; 113. Impact Factor-7.7
3. Italiya, K. S., Basak, M., Mazumdar, S., Sahel, D. K., Shrivastava, R., Chitkara, D., & Mittal, A. Scalable Self-Assembling Micellar System for Enhanced Oral Bioavailability and Efficacy of Lisofylline for Treatment of Type-I Diabetes. Molecular pharmaceutic. 2019 (16) 4954-4967. Impact Factor-4.3
4. Shrivastava, R., and N. Shukla. Attributes of alternatively activated (M2) macrophages. Life Sci 2019 (224) 222-231. Impact Factor-3.2
5. Shrivastava, R., Trivedi, S., Singh, Pankaj., Mohammad, A., Khanna, Amit., Bhadauria, S. Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity. Biochemical and Biophysical Research Communications. 2018 (503) 677-683. Impact factor-2.5
6. Shrivastava, R., Mohammad, A., Singh, V., Dubey, P., Malik, S.A., Lone, M.U.D., Tewari, B.N., Baghel, K.S., Pal S., Nagar G.K., Chattopadhyay N., Bhadauria, S. M2 Polarization of Macrophages by Oncostatin M in Hypoxic Tumor Microenvironment is Mediated by mTORC2 and Promotes Tumor Growth and Metastasis. Cytokine 2018 S1043-4666(18) 30118-2. Impact Factor-3.5
7. Shrivastava, R., Singh, V., Mohammad, A., Negi, MPS., Bhadauria, S. Oncostatin M Upregulates HIF-1α in Breast Tumor-Associated Macrophages Independent of Intracellular Oxygen Concentration. Life sciences, Feb 2018 1;194:59-66. Impact Factor-3.5
8. Y.Singh, V.K.Pawar, J.G. Meher, K. Raval, A. Kumar, R. Shrivastava, Bhadauria S., M. K. Chourasia, Targeting tumour-associated macrophages (TAM’s) via nanocarriers. Journal of Controlled Release, 254(2017) 92-106. Impact Factor-7.7
9. Singh S., Shrivastava R., Singh G., Ali R., Bhadauria S., Ampapathi RS., Haq W., AzaGly Appended peptidomimetics structurally related to PTR6154 as Potential PKB/Akt inhibitors. Chembiochem, 2017. 18(12):1061-1065. Impact Factor-2.8
10. Lone, M.U.D., Baghel, K.S., Kanchan, R.K., Shrivastava, R., Malik, S.A., Tewari, B.N., Tripathi, C., Negi, M.P.S., Garg, V.K., Sharma, M. and Bhatt, M.L.B. and Bhadauria, S. Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.− upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells. Oncogene.2016. 36(13):1829-1839. Impact Factor-7.5
11. Baghel, K.S., Tewari, B.N., Shrivastava, R., Malik, S.A., Lone, M.U.D., Jain, N.K., Tripathi, C., Kanchan, R.K., Dixit, S., Singh, K. and Mitra, K. Bhadauria., S. Macrophages promote matrix protrusive and invasive function of breast cancer cells via MIP-1β dependent upregulation of MYO3A gene in breast cancer cells. Oncoimmunology, 2016 5(7), p.e1196299. Impact Factor-7.6
12. Shrivastava, R., and Bhadauria, S., Role of Growth Factor Signaling in cancer. Defence Life Science Journal, 2016 Vol1, Pg no. 34-47.
13. M Mittal M., Pal S., China S.P., Porwal K., Dev K., Shrivastava R., Raju K.R.S, M Rashid M., Trivedi A.K., Sanyal S., Wahajuddin M., Bhaduria S., Maurya R., Chattopadhyay N., Pharmacological activation of aldehyde dehydrogenase 2 promotes osteoblast differentiation via bone morphogenetic protein-2 and induces bone anabolic effect. Toxicology and Applied Pharmacology, 2016;319, 63:73. Impact Factor-3.7
14. Pal S, Khan, K., China, S.P., Mittal, M., Shrivastava, R., Taneja, I., Hossain, Z., Mandalapu, D., Gayen, J.R., Wahajuddin, M. and Sharma, V.L., Trivedi A.K., Sanyal S., Bhadauria S, Godbole S ,S K. Gupta , Chattopadhyay N. Theophylline, a methylxanthine drug induces osteopenia and alters calciotropic hormones, and prophylactic vitamin D treatment protects against these changes in rats. Toxicology and Applied Pharmacology, 2016. 295, :12-25. Impact Factor-3.7
15. Shrivastava, R., Dubey, P., Tripathi, C., Jain, N.K., Tewari, B.N., Lone, M.U., Baghel, K.S., Kumar, V., Misra, S., Bhadauria, S. and Bhatt, M.L. Cyclooxygenase-2 inhibition attenuates hypoxic cancer cells induced M2-polarization of macrophages. Cellular and molecular biology (Noisy-le-Grand, France), 60(3), 2014 pp.10-15. Impact Factor- 1.4
16. Tripathi, C., Tewari, B.N., Kanchan, R.K., Baghel, K.S., Nautiyal, N., Shrivastava, R., Kaur, H., Bhatt, M.L.B. and Bhadauria, S. Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin. Oncotarget, 2014. 5(14), p.5350-5368. Impact Factor-5.08